STOCK BASED COMPENSATION (Tables)
|
6 Months Ended |
Jun. 30, 2022 |
|---|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
| Schedule of option activity |
The option activity of the Plans for the six months ended June 30, 2022, is as follows (shares in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-Average |
|
|
|
|
|
|
|
Weighted-Average |
|
Remaining |
|
Aggregate |
|
|
Number of |
|
Exercise Price |
|
Contractual Term |
|
Intrinsic Value |
|
|
Shares |
|
per Share |
|
(in years) |
|
(in thousands) |
Outstanding at January 1, 2022 |
|
13,249 |
|
$ |
1.73 |
|
7.23 |
|
$ |
42,775 |
Granted |
|
— |
|
$ |
|
|
|
|
|
|
Exercised |
|
(1,021) |
|
$ |
1.24 |
|
|
|
|
|
Forfeited/expired |
|
(1,836) |
|
$ |
1.46 |
|
|
|
|
|
Outstanding at June 30, 2022 |
|
10,392 |
|
$ |
1.82 |
|
6.64 |
|
$ |
6,220 |
Options vested at June 30, 2022 |
|
8,217 |
|
$ |
1.89 |
|
6.32 |
|
$ |
4,588 |
Options vested or expected to vest at June 30, 2022 |
|
10,365 |
|
$ |
1.82 |
|
6.64 |
|
$ |
6,199 |
|
| RSU activity under the Plan |
The activity for stock subject to vesting as of June 30, 2022, is as follows (shares in thousands):
|
|
|
|
|
|
|
Shares Subject |
|
Weighted-Average |
|
|
to Vesting |
|
Grant Date Fair Value |
Balance of unvested shares as of January 1, 2022 |
|
264 |
|
$ 7.79 |
Cancelled/Forfeited |
|
(5) |
|
$ 8.78 |
Vested |
|
(113) |
|
$ 6.47 |
Balance of unvested shares as of June 30, 2022 |
|
146 |
|
$ 7.79 |
|
| Schedule of RSU activity |
RSU activity under the 2020 Plan for the six months ended June 30, 2022, is as follows (shares in thousands):
|
|
|
|
|
|
|
Shares Subject |
|
Weighted-Average |
|
|
to Vesting |
|
Grant Date Fair Value |
Balance of unvested shares as of January 1, 2022 |
|
16,395 |
|
$ 7.54 |
Granted |
|
7,988 |
|
$ 3.64 |
Vested |
|
(2,483) |
|
$ 11.18 |
Cancelled/Forfeited |
|
(2,622) |
|
$ 7.70 |
Balance of unvested shares as of June 30, 2022 |
|
19,278 |
|
$ 5.43 |
|
| Schedule of stock-based compensation expense |
Total stock-based compensation expense related to all of the Company’s stock-based awards granted is reported in the consolidated statements of operations as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
|
2022 |
|
2021 |
|
2022 |
|
2021 |
Research and development(1) |
|
$ |
12,797 |
|
$ |
1,838 |
|
$ |
17,517 |
|
$ |
2,755 |
General and administrative expense |
|
|
4,362 |
|
|
1,355 |
|
|
7,782 |
|
|
2,194 |
Sales and marketing expense |
|
|
1,388 |
|
|
577 |
|
|
2,673 |
|
|
921 |
Cost of sales |
|
|
671 |
|
|
229 |
|
|
1,158 |
|
|
346 |
Total stock-based compensation expense |
|
$ |
19,218 |
|
$ |
3,999 |
|
$ |
29,130 |
|
$ |
6,216 |
(1) Includes $7.3 million of stock-based compensation expense during the three and six months ended June 30, 2022, incurred in connection with the Initiative described in Note 24. Restructuring Charges.
|
| Assumed Stock Options |
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
| Schedule of assumptions using Black-Scholes option-pricing model |
|
|
|
|
|
|
|
|
As of November 12, 2021 |
Risk‑free interest rate |
|
|
0.5% – 0.8 |
|
Expected volatility |
|
|
57.2% – 59.4 |
% |
Expected life (in years) |
|
|
1.0 – 2.8 |
|
Expected dividend yield |
|
|
— |
|
Fair value of Common Stock |
|
$ |
8.61 |
|
|
| Market Based Restricted Stock Units |
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
| Schedule of assumptions using Black-Scholes option-pricing model |
The table below sets forth the assumptions used to value the market-based awards and the estimated grant-date fair value:
|
|
|
|
|
|
|
October 2021 |
|
|
Awards |
Risk-free interest rate |
|
|
1.3 |
% |
Expected dividend yield |
|
|
— |
% |
Remaining performance period (in years) |
|
|
7.0 |
|
Expected volatility |
|
|
55.0 |
% |
Estimated grant date fair value (per share) |
|
$ |
0.98 – 4.95 |
|
Target performance (number of shares) |
|
|
9,070,269 |
|
|